Pinnacle Financial Partners (Tennessee)’s United Therapeutics UTHR Stock Holding History

Pinnacle Financial Partners (Tennessee)’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$217K	Buy	+518	New	+$174K	0.01%	446

Other funds holding UTHR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Pinnacle Financial Partners (Tennessee)'s UTHR Position: Q3 2025 in Review

Pinnacle Financial Partners (Tennessee) opened a new position in United Therapeutics (UTHR) in Q3 2025: 518 shares worth $217K. The stake represents 0.01% of the portfolio and ranks #446 among its holdings.

708 funds tracked by Wall St. Rank hold UTHR as of Q3 2025.

Pinnacle Financial Partners (Tennessee) held 518 shares of United Therapeutics worth $217K as of Q3 2025.
United Therapeutics was a new Pinnacle Financial Partners (Tennessee) position in Q3 2025.
United Therapeutics made up 0.01% of Pinnacle Financial Partners (Tennessee)'s portfolio in Q3 2025, its #446 holding.
708 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2025.

Based on Pinnacle Financial Partners (Tennessee)'s 13F filing for Q3 2025, filed 28 Oct 2025.